Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract
Open Access
- 1 August 2003
- Vol. 98 (6) , 1273-1282
- https://doi.org/10.1002/cncr.11621
Abstract
BACKGROUND The molecular pathogenesis of poorly differentiated endocrine carcinomas of the gastrointestinal tract (GI PDECs) remains unclear. It has been suggested that these lesions either originate from multipotent stem cells that also can serve as the origin of nonendocrine adenocarcinomas or arise due to the dedifferentiation of well-differentiated endocrine carcinomas (WDECs). METHODS Ten gastric and 9 colorectal PDECs, 9 gastric WDECs, and 12 colorectal carcinomas (CRCs) were analyzed for loss of heterozygosity (LOH) at 11q13 (MEN1), 17p13.1 (p53), 3p14.2 (FHIT), 3p21.3 (RASSF1A), and 18q23 (DCC/DPC4/Smad2), and for immunohistochemical expression of p53, FHIT, Rb, and p16. RESULTS PDECs exhibited high fractional allelic loss (FAL; 0.49), with frequent (> 40%) alterations in p53, Rb, MEN1, FHIT, and 18q. No significant differences were found between gastric and colorectal PDECs. Gastric WDECs also exhibited high FAL (0.44), with frequent alterations in Rb and/or p16, MEN1, and 3p21. CRCs exhibited a low level of FAL (0.23), with frequent (> 50%) p16 and p53 alterations. When gastric PDECs and WDECs were compared, substantial similarities were found with respect to FAL (0.42 vs. 0.44) and with respect to individual gene alterations, except in p53, which was consistently altered only in PDECs. CRCs, which were characterized by a lower FAL (0.56 vs. 0.23) and which lacked alterations in both 3p and Rb, were found to be significantly different from colorectal PDECs. CONCLUSIONS GI PDECs demonstrated a high level of chromosomal instability; consistent inactivation of both the p53 and p16/Rb pathways; and frequent LOH at 3p (possibly involving FHIT), the MEN1 locus, and 18q. The profile of genetic alterations in PDECs was more consistent with the profile in WDECs than with the profile in CRCs. Cancer 2003;98:1273–82. © 2003 American Cancer Society. DOI 10.1002/cncr.11621Keywords
This publication has 38 references indexed in Scilit:
- RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancerOncogene, 2002
- The colorectal adenoma–carcinoma sequenceBritish Journal of Surgery, 2002
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomasThe Journal of Pathology, 2002
- Extensive characterization of genetic alterations in a series of human colorectal cancer cell linesOncogene, 2001
- Comparative Genomic Hybridization Identifies Loss of 18q22-qter as an Early and Specific Event in Tumorigenesis of Midgut CarcinoidsThe American Journal of Pathology, 2001
- Chromosome 18 deletions are common events in classical midgut carcinoid tumorsInternational Journal of Cancer, 2001
- Overexpression of Cyclin D1 Occurs Frequently in Human Pancreatic Endocrine TumorsJournal of Clinical Endocrinology & Metabolism, 2000
- Differential retinoblastoma and p16INK4A protein expression in neuroendocrine tumors of the lungCancer, 2000
- Aggressive Forms of Gastric Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type IThe American Journal of Surgical Pathology, 1997